CoChat

Role of bile acids in inflammatory liver diseases

Open access
Evangelakos, Ioannis, Heeren, Joerg, Verkade, Esther, Kuipers, Folkert · 2021 · Seminars in Immunopathology

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Abstract

Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering with microbiome composition may be beneficial for cholestatic and metabolic liver diseases by modulating formation of secondary bile acids, as different bile acid species have different signaling functions. Bile acid receptors such as FXR, VDR, and TGR5 are expressed in a variety of cells involved in innate as well as adaptive immunity, and specific microbial bile acid metabolites positively modulate immune responses of the host. Identification of Cyp2c70 as the enzyme responsible for the generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition. These novel mouse models will aid to accelerate translational research on the (patho)physiological roles of bile acids in human liver diseases .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00281-021-00869-6

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Generation of primary and secondary bile acids. Cholesterol is converted by a series of oxidative reactions to the primary bile acids, cholic acid (CA), and chenodeoxycholic acid (CDCA). In response to a meal, the conjugated forms of primary bile acids are released into the small intestine where they play an important role in digestion of dietary lipids. In the ileum of the intestine, approximately 95% of bile acids are reabsorbed and return to the liver via the enterohepatic circulation. In the colon, primary bile acids are deconjungated and converted by a number of bacterial enzymes to secondary bile acids such as deoxycholic acid (DCA) or lithocholic acid (LCA), which can be excreted or follow the enterohepatic circulation. As indicated in red, in mice bile acids are primarily conjugated to taurine (T), while human bile acids are conjugated to glycine (G). Notably, murine bile acids known as muricholic acids (MCA) are generated by CYP2C70, an enzyme expressed in murine but not in human liver explaining the difference in the composition of human and murine bile acid species
Fig. 1 Generation of primary and secondary bile acids. Cholesterol is converted by a series of oxidative reactions to the primary bile acids, cholic acid (CA), and chenodeoxycholic acid (CDCA). In response to a meal, the conjugated forms of primary bile acids are released into the small intestine where they play an important role in digestion of dietary lipids. In the ileum of the intestine, approximately 95% of bile acids are reabsorbed and return to the liver via the enterohepatic circulation. In the colon, primary bile acids are deconjungated and converted by a number of bacterial enzymes to secondary bile acids such as deoxycholic acid (DCA) or lithocholic acid (LCA), which can be excreted or follow the enterohepatic circulation. As indicated in red, in mice bile acids are primarily conjugated to taurine (T), while human bile acids are conjugated to glycine (G). Notably, murine bile acids known as muricholic acids (MCA) are generated by CYP2C70, an enzyme expressed in murine but not in human liver explaining the difference in the composition of human and murine bile acid speciesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 108 references

Cited by

See all 121

Metadata

Authors
Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F.
Affiliations
  • University Medical Center Hamburg-Eppendorf (DE)
  • University Medical Center Groningen (NL)
Venue
Seminars in Immunopathology
Published
2021-07-08
Volume
43
Issue
4
Pages
577-590
ISSN
  • 1863-2297 (ISSN-L)
  • 1863-2300
OpenAlex
W3179865180
Cited by
121
References
107
Citations by year
2026: 23 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 5
FWCI
2.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Seminars in Immunopathology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (SFB841)
  • ICIN Netherlands Heart Institute (DCVA grant 2018-27)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
bile acids, bile acid signaling, inflammatory liver disease, cholestatic liver disease, metabolic liver disease, gut microbiota, secondary bile acids, farnesoid X receptor, vitamin D receptor, TGR5, immune regulation, muricholic acids, humanized mice, bile acid receptors
MeSH terms
Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Humans, Liver, Liver Diseases, Signal Transduction, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of bile acids in inflammatory liver diseases. https://app.cochat.ai/papers/10.1007/s00281-021-00869-6
The paper
Evangelakos, I., Heeren, J., Verkade, E., & Kuipers, F. (2021). Role of bile acids in inflammatory liver diseases. Seminars in Immunopathology. https://doi.org/10.1007/s00281-021-00869-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.